Klinične študije za BOPC v Colorado
15 študij za BOPC išče udeležence na lokacijah v Colorado.
Mesta v Colorado
Uradno besedilo študije (angleško)
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Research Site, Aurora
- Research Site, Denver
Vključevanje udeležencevFaza 3
Starost 40–80 · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT06283966Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
- Alpine Clinical Research Center - Boulder - 47th Street- Site Number : 8400005, Boulder
- Critical Care Pulmonary & Sleep Associates- Site Number : 8400081, Lakewood
Vključevanje udeležencevFaza 3
Starost 40–80 · Vsi spoli · Posodobljeno 1. okt. 2026 · NCT07190222To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment
- Lynn Institute of Denver, Aurora
Vključevanje udeležencevFaza 2
Starost 40–85 · Vsi spoli · Posodobljeno 30. sep. 2026 · NCT07684820A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
- National Jewish Health Medical Center, Denver
Vključevanje udeležencevFaza 2
Starost 40–75 · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT07759245An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema
- UCHealth - Medical Center of the Rockies, Loveland
Vključevanje udeležencev
Starost 40–80 · Vsi spoli · Posodobljeno 17. sep. 2026 · NCT06035120Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
- National Jewish Health, Denver
Vključevanje udeležencevFaza 2
Starost 40 in več · Vsi spoli · Posodobljeno 4. sep. 2026 · NCT07059091eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
- GSK Investigational Site, Lakewood
Vključevanje udeležencevFaza 3
Starost 40–75 · Vsi spoli · Posodobljeno 28. jul. 2026 · NCT07177339MoblO2 to Maintain Oxygenation
- National Jewish Health, Denver
Vključevanje udeležencev
Starost 25–95 · Vsi spoli · Posodobljeno 22. jul. 2026 · NCT07704567SPIROMICS Study of Early COPD Progression (SOURCE)
- National Jewish Health, Denver
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
Starost 30–55 · Vsi spoli · Posodobljeno 3. jun. 2026 · NCT05033990Breathe Easier With Tadalafil Therapy for Dyspnea in COPD-PH
- Rocky Mountain Regional VA Medical Center, Aurora, CO, Aurora
Vključevanje udeležencevFaza 2
Starost 35–89 · Vsi spoli · Posodobljeno 15. maj 2026 · NCT05937854Phenotyping Resting and Exertional Right Ventricular Dysfunction Among Patients With Chronic Obstructive Pulmonary Disease
- University of Colorado Anschutz Medical Campus, Aurora
Vključevanje udeležencev
Starost 40 in več · Vsi spoli · Posodobljeno 8. maj 2026 · NCT05896579Right Ventricular Response to Exercise Among Patients With Chronic Obstructive Pulmonary Disease
- University of Colorado Anschutz Medical Campus, Aurora
Vključevanje udeležencev
Starost 40 in več · Vsi spoli · Posodobljeno 8. maj 2026 · NCT07576894Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
- GSK Investigational Site, Aurora
Vključevanje udeležencevFaza 3
Starost 40–80 · Vsi spoli · Posodobljeno 9. apr. 2026 · NCT06961214PiMZ Longitudinal Cohort (PiMZ Logic)
- National Jewish Health, Denver
Vključevanje udeležencevOpazovalna študija
Starost 18 in več · Vsi spoli · Posodobljeno 16. jan. 2026 · NCT06505603PRagmatic EVAluation of a Quality Improvement Program for People Living With Modifiable High-risk COPD.
- University of Colorado, Denver
Vključevanje udeležencev
Starost 18 in več · Vsi spoli · Posodobljeno 12. okt. 2023 · NCT05306743Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.